Artesunate-amodiaquine fixed dose combination for the treatment of Plasmodium falciparum malaria in India (Q35955433)

11 August 2017

Artesunate-amodiaquine fixed dose combination for the treatment of Plasmodium falciparum malaria in India (English)

1 reference

Plasmodium falciparum malaria

11 August 2017

Plasmodium falciparum

0 references

0 references

0 references

0 references

0 references

1 reference

11

Neena Valecha

1 reference

11 August 2017

Anupkumar R Anvikar

1

1 reference

11 August 2017

Bhawna Sharma

2

1 reference

11 August 2017

Bhartendu H Shahi

3

1 reference

11 August 2017

Prajesh K Tyagi

4

1 reference

11 August 2017

Tarit K Bose

5

1 reference

11 August 2017

Surya K Sharma

6

1 reference

11 August 2017

Prakriti Srivastava

7

1 reference

11 August 2017

Bina Srivastava

8

1 reference

11 August 2017

Jean R Kiechel

9

1 reference

11 August 2017

Aditya P Dash

10

1 reference

11 August 2017

30 March 2012

1 reference

11 August 2017

1 reference

11 August 2017

11

1 reference

11 August 2017

97

1 reference

https://scigraph.springernature.com/pub.10.1186/1475-2875-11-97

11 August 2017

0 references

cites work

Compliance, safety, and effectiveness of fixed-dose artesunate-amodiaquine for presumptive treatment of non-severe malaria in the context of home management of malaria in Madagascar

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3351019

Repeated treatment of recurrent uncomplicated Plasmodium falciparum malaria in Senegal with fixed-dose artesunate plus amodiaquine versus fixed-dose artemether plus lumefantrine: a randomized, open-label trial

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3351019

Two-year evaluation of intermittent preventive treatment for children (IPTc) combined with timely home treatment for malaria control in Ghana.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3351019

Antimalarial drug resistance of Plasmodium falciparum in India: changes over time and space

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3351019

Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3351019

Efficacy and tolerability of artesunate-amodiaquine (Camoquin plus) versus artemether-lumefantrine (Coartem) against uncomplicated Plasmodium falciparum malaria: multisite trial in Senegal and Ivory Coast

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3351019

Randomized, multicentre assessment of the efficacy and safety of ASAQ--a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3351019

Comparative efficacy of antimalarial drugs including ACTs in the treatment of uncomplicated malaria among children under 5 years in Ghana

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3351019

Malaria in the Nuba Mountains of Sudan: baseline genotypic resistance and efficacy of the artesunate plus sulfadoxine-pyrimethamine and artesunate plus amodiaquine combinations

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3351019

Drug resistant falciparum malaria and the use of artesunate-based combinations: focus on clinical trials sponsored by TDR.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3351019

A randomized trial of amodiaquine and artesunate alone and in combination for the treatment of uncomplicated falciparum malaria in children from Burkina Faso

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3351019

Plasmodium falciparum isolates in India exhibit a progressive increase in mutations associated with sulfadoxine-pyrimethamine resistance

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3351019

Systematic review of amodiaquine treatment in uncomplicated malaria

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3351019

Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial

2 October 2017

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1475-2875-11-97

Low efficacy of chloroquine: time to switchover to artemisinin-based combination therapy for falciparum malaria in India

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1475-2875-11-97

Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in Thailand.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1475-2875-11-97

21 January 2018

Identifiers

DOI

10.1186/1475-2875-11-97

1 reference

Dimensions Publication ID

11 August 2017

0 references

1 reference

11 August 2017

1 reference